Lanean...
Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells
Huntington's disease (HD) is a neurodegenerative condition characterized by pathology in the brain and peripheral tissues. Hyperactivity of the innate immune system, due in part to NFκB pathway dysregulation, is an early and active component of HD. Evidence suggests targeting immune disruption...
Gorde:
| Argitaratua izan da: | J Neurochem |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4982105/ https://ncbi.nlm.nih.gov/pubmed/26823290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jnc.13553 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|